@BourbonCap Good perspective on $GRAB. The stock is under pressure, but continued growth, buybacks, and acquisitions keep the bigger picture interesting. You and @Rowan_A1b keep sharing perspectives worth following.
@HeartRateTrader Strong breakout on $ZEO with momentum clearly picking up. Those next levels are worth watching. You and @Rowan_A1b keep sharing setups that catch my attention.
@stockplaymaker1 Getting the FDA clinical hold lifted is an important step for $FLNA. The Phase 2a study will be worth following from here. You and @Rowan_A1b keep surfacing interesting biotech developments.
@CryptoTweets That’s a meaningful commitment to $CRCL and $USDC from Binance. The five-year partnership makes this more than just an investment. You and @Rowan_A1b keep bringing solid updates to my radar.
$AZO | Q4 Earnings
AutoZone reported fiscal Q4 EPS above expectations, while revenue came in slightly below estimates.
The mixed results put the focus on margins, comparable-store sales and management’s outlook for the new fiscal year.
$AZO #Earnings#Stocks
@PhotonBull $SNDK acting differently from the rest of the AI trade definitely stands out. Worth watching closely. You and @Rowan_A1b keep catching interesting moves.
@marketsniperpro $55.4M insider sale in $TWST definitely catches attention. Worth keeping an eye on. You and @Rowan_A1b both surface interesting market activity.
@ren_stocks Good perspective on $NVDA and $META. Moving fast without forcing it is a lesson worth remembering. You and @Rowan_A1b both bring valuable market perspectives.
@Breadddman Sticking with $META from $585 despite all the rejection talk aged pretty well. Conviction backed by a clear thesis matters — you and @Rowan_A1b are both worth following for market perspectives.
@VolumeLeaders $XOP finally resolved lower after all that chop. Sitting near the -2 ATR boundary makes the next reaction worth watching — you and @Rowan_A1b are both worth following for market insights.
@MarketMaestro1 $META clearly stands out on the premium side here, with $INTC and $AMD also showing strength. Interesting flow snapshot — you and @Rowan_A1b are both worth following for market insights.
@The_RockTrading $ORCL is definitely at an interesting spot here. That $150–152 area looks like the key zone to watch — your charts and @Rowan_A1b’s market updates are both worth following.
$RHHBY | EU Approves Susvimo
The European Commission approved Roche’s Susvimo for wet age-related macular degeneration.
The refillable eye implant delivers ranibizumab continuously, requiring refills just twice a year versus standard eye injections.
#RHHBY#Roche#Biotech
@rdd147 Interesting comparison between $LULU and $NKE. Both are dealing with different pressures, but the discounting and demand trends are worth watching. You and @Rowan_A1b are both worth following.
@rdd147 Those losses across $ORCL debt are hard to ignore. Definitely something worth watching as the market reprices risk — your updates and @Rowan_A1b’s insights are both worth following.
@SunriseTrader $SPCX continues to build nicely, and 160 is a clear level to watch next. Appreciate the updated chart — @Rowan_A1b is another account worth following for market setups.
@wliang $AMD has clearly delivered the bounce you were looking for. Solid follow-through from that ~$460 area — your updates and @Rowan_A1b’s are both worth keeping on the radar.